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Introduction: Patients undergoing hematopoietic cell
transplantation (HCT) have an increased risk of Clostridium
difﬁcile infection (CD). Literature reports CD infection in
nearly 20% of transplanted patients. No information about
this infection in HCT patients has been reported in Chile.
Patients and Methods: We performed a retrospective
analysis of 250 patients undergoing HCT at the Catholic
University Hospital in Santiago, Chile, between 2000 and
2013. Statistical analysis of the data was conducted using
SPSS Statistics v21.
Results: Of the 250 transplanted patients studied, 59%
(n¼147) were allo-HCT and 41% (n¼103) were auto-HCT. The
mean age was 39 years old (range, 15-69), with a male
predominance (151 patients; 60%). Main indications for HCT
were acute leukemia (n¼104; 42%), multiple myeloma
(n¼36; 14%) and lymphoma (n¼49; 20%). 93% of patients
received myeloablative (MA) regimens, and all of them
received proton pump inhibitors and prophylactic antibiotics
the previous months of the HCT. Of the 250 patients studied,
192 (77%) had at least one episode of diarrhea that required
study, among them 13% (n¼25) were documented as positive
for CD (toxin assay or PCR test), the mean age of this group
was 36 years old (range, 18-62), with a male predominance
(15 patients, 60%). All of the infected patients had mild to
moderate diseases and there were no deaths attributed to it.
80% (n¼20) of the infected patients underwent allo-HCT and
20% (n¼5) auto-HCT. In the allo-HCT group, 53% had acute
lymphoblastic leukemia, 6% acute myeloid leukemia, 24%
chronic myeloid leukemia and 12% other causes. In the
auto-HCT group, 40% were transplanted due to multiple
myeloma, 20% amyloidosis, 20% germinal cancer and 20%
acute myeloid leukemia. No patient required total central
parenteral nutrition previous to the infection. During the 3
months before HCT, 84% (n¼21) of the infected patients
used antibiotics including cephalosporins, carbapenem,
aminoglicosides and vancomycin. The overall incidence of CD
infection in the ﬁrst week, month and year after transplant,
was 4%, 6% and 10%, respectively, with a median time frame
from transplantation to infection diagnosis of 20 days. In
auto-HCT, 7 days, 30 days and 1 year CD incidence was 2, 3
and 5%, respectively. In allo-HCT, 7 days, 30 days and 1 year
CD incidence was 5, 9 and 14%, respectively. There was no
signiﬁcant statistical difference in overall survival (OS)
between the infected and non-infected patients one year
after the transplant (OS 68% for CD negative vs. 72% for CD
positive, p¼0.61).
Conclusions: In our institution CD infection in patients
undergoing HCT had a similar incidence to other reports.
Most of cases occur before the ﬁrst week after HCT (40% of
the cases), and the remained stable afterwards. We identiﬁed
the type of transplant (allo-HCT 3 times higher risk than
auto-HCT) and disease (ALL 3 times higher risk than AML) as
risk factors for CD infection.361
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hematologic malignancies and hematopoietic cell trans-
plantation (HCT). Optimal nutritional status is associated
with a shorter time of engraftment and less infection rates
during the initial phase. We present our experience in
nutritional assessment pre and post transplantation.
Objective: To evaluate the possible association between
nutritional parameters and outcomes such as overall survival
and speciﬁc complications, in patients who underwent HCT.
Patients and Methods: Retrospective study in patients with
HCT between June 2011 and May 2014 in our center. We
assessed nutritional status before transplantation and then
10 days after it. Nutritional assessment included anthro-
pometry, body mass index (BMI), albumin, prealbumin and
total urinary nitrogen (TUN). Statistical analysis was made
using IBP SSPS v.20.
Results:We studied a total of 50 patients between June 2011
andMay 2014. Media following time: 35months. Median age
was 41 years (18-67), 33 (66%) were male and 17 (33%)
female. Thirty two underwent (64%) allogeneic HCT and 18
(36%) autologous HSCT, with 42 undergoing (84%) myeloa-
blative conditioning and 8 (16%) reduced intensity condi-
tioning. Diagnoses included acute leukemia (26), lymphoma
(7), multiple myeloma (13), and aplastic anemia (3). Thirty
seven patients developed mucositis and 31 required paren-
teral nutrition (PN). Twenty three patients developed
mucositis and required PN (mild: 2, moderate: 20, severe: 1)
Incidence of mucositis between allogeneic and autologous
HCT that required PN was similar (75% vs 72%). Albumin
levels were 4,1mg/dL before and 3,3 mg/dL 10 days after
HSCT (p<0,05). No difference was found between BMI,
dynamometry and TUN before and after HCT. TUN before
HCT was associated with more days of PN (p<0,05). Multi-
variate analysis showed an association between lower
albumin levels after HCT and PN requirement, as well as a
longer length of stay. High TUN and lower albumin levels
after HCT were associated with longer platelet engraftment
time (p<0,05). Longer engrafment time was associated with
longer duration of PN (p<0,05). Nine patients (28%) in the
allogeneic group developed acute gastrointestinal graft
versus host disease (GVHD) that required prolonged PN. No
association was found between BMI, albumin, prealbumin,
TUN or requirement of PN, with the risk of mucositis or
infectious complications. None of the evaluated nutritional
parameters were associated with overall survive (OS).
Conclusion: High catabolism was associated with a longer
length of stay, the requirement of PN and a prolonged
platelet engraftment time. Acute gastrointestinal GVHD was
associated with more requirement and a longer duration of
PN. Nutritional parameters were not associated with any risk
of infection and OS.362
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Plerixafor (P) is highly effective at mobilizing peripheral
blood stem cells. Most centers, including our own, have an
algorithm that utilizes P in patients who are predicted to
have poor collections using G CSF alone, based on peripheral
